8-KEarnings & ResultsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Results (Jul 23, 2026)

Filed July 23, 2026For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) has filed an 8-K report on July 23, 2026, to announce its financial results for the second quarter of 2026. While the filing itself is brief, it directs investors to a furnished press release (Exhibit 99.1) for the detailed financial performance and operational updates. Investors should review this press release to understand the company's revenue, profitability, and any forward-looking statements or guidance provided for the remainder of fiscal year 2026. The primary purpose of this 8-K is to make the Q2 2026 earnings announcement publicly available in accordance with SEC regulations. The information contained within the press release is crucial for assessing the company's current financial health and its trajectory. Key metrics such as sales growth, earnings per share (EPS), and any significant developments in their product pipeline or regulatory landscape will be the focus for investors seeking to evaluate EW's performance against market expectations and historical trends.

Key Highlights

  • 1Edwards Lifesciences (EW) reported its financial results for the second quarter of 2026 on July 23, 2026.
  • 2The official announcement and detailed financial data are provided in a press release furnished as Exhibit 99.1.
  • 3Investors are directed to Exhibit 99.1 for a comprehensive understanding of Q2 2026 performance.
  • 4This filing serves as a formal notification of the company's financial performance for the period.
  • 5The information furnished is not considered 'filed' for the purposes of the Securities Exchange Act of 1934, but is incorporated by reference.

Frequently Asked Questions

The detailed financial results for the second quarter of 2026 are available in the press release furnished as Exhibit 99.1 to this 8-K filing.

This 8-K filing formally announces that Edwards Lifesciences has released its Q2 2026 financial results, directing investors to the accompanying press release for all pertinent financial and operational details.

This 8-K filing itself does not contain specific financial figures. All the detailed financial metrics, including revenue, earnings per share, and other operational highlights, are presented in the press release referenced as Exhibit 99.1.

When information is 'furnished' under Item 2.02, it means the company is providing the information to the SEC but is not subject to the same liability rules as if it were 'filed' under Section 18 of the Exchange Act. However, the information is still incorporated by reference and can be relied upon by investors.